UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1489) 1489
humans (1427) 1427
life sciences & biomedicine (1384) 1384
hepacivirus - enzymology (1268) 1268
hepacivirus - genetics (820) 820
hepatitis c virus (677) 677
hepacivirus - drug effects (651) 651
viral nonstructural proteins - metabolism (596) 596
viral nonstructural proteins - antagonists & inhibitors (566) 566
male (505) 505
female (472) 472
antiviral agents - pharmacology (449) 449
hepatitis c (429) 429
middle aged (410) 410
adult (393) 393
virology (369) 369
viral nonstructural proteins - genetics (367) 367
pharmacology & pharmacy (344) 344
biochemistry & molecular biology (332) 332
animals (331) 331
antiviral agents - therapeutic use (315) 315
viruses (314) 314
viral nonstructural proteins - chemistry (313) 313
gastroenterology & hepatology (295) 295
genotype (294) 294
hepatitis c - virology (276) 276
virus diseases (267) 267
hepatitis c - drug therapy (264) 264
antiviral agents - chemistry (260) 260
hepatitis c - enzymology (256) 256
models, molecular (256) 256
hepatitis (254) 254
molecular sequence data (253) 253
alanine transaminase - blood (250) 250
structure-activity relationship (238) 238
hepatitis c, chronic - drug therapy (216) 216
enzyme inhibitors - pharmacology (213) 213
antiviral agents (212) 212
microbiology (202) 202
binding sites (200) 200
hepacivirus - physiology (200) 200
aged (199) 199
amino acid sequence (194) 194
cell line (192) 192
hepatitis c, chronic - virology (179) 179
hcv (178) 178
digestive system diseases (176) 176
rna (176) 176
rna, viral - blood (173) 173
proteases (171) 171
infectious diseases (166) 166
rna replicase - antagonists & inhibitors (166) 166
virus replication - drug effects (166) 166
interferon-alpha - therapeutic use (163) 163
rna replicase - metabolism (163) 163
hepacivirus - isolation & purification (161) 161
physical sciences (159) 159
protein binding (158) 158
chemistry (157) 157
hepatitis c, chronic - enzymology (157) 157
protease inhibitors - pharmacology (156) 156
drug therapy, combination (155) 155
treatment outcome (154) 154
analysis (152) 152
hepacivirus - immunology (151) 151
liver - enzymology (149) 149
base sequence (147) 147
interferon (141) 141
proteins (141) 141
health aspects (138) 138
mutation (138) 138
chemistry, medicinal (136) 136
enzymes (136) 136
enzyme inhibitors - chemistry (133) 133
molecular structure (132) 132
kinetics (131) 131
rna, viral - genetics (129) 129
cell line, tumor (127) 127
research article (126) 126
hepacivirus (124) 124
antiviral agents - chemical synthesis (121) 121
liver - pathology (120) 120
protease inhibitors (120) 120
research (117) 117
liver (115) 115
protein conformation (115) 115
ribavirin - therapeutic use (115) 115
drug design (112) 112
virus replication (110) 110
recombinant proteins (106) 106
hepacivirus - metabolism (104) 104
crystallography, x-ray (103) 103
rats (103) 103
antiviral agents - adverse effects (102) 102
genetic aspects (102) 102
substrate specificity (101) 101
immunology (100) 100
infections (99) 99
drug resistance, viral (97) 97
viral load (96) 96
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1925) 1925
Japanese (14) 14
German (12) 12
Russian (12) 12
Chinese (11) 11
Portuguese (7) 7
Spanish (7) 7
Hungarian (6) 6
French (5) 5
Turkish (3) 3
Dutch (1) 1
Hebrew (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, pp. e45285 - e45285
A role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Liver - virology | Hepatitis C, Chronic - pathology | Liver - enzymology | Gene Expression - drug effects | Apoptosis - drug effects | ATP Binding Cassette Transporter, Sub-Family B - deficiency | Carbon Tetrachloride | Humans | NADPH Oxidases - metabolism | Hepatitis C, Chronic - virology | Myofibroblasts - enzymology | Liver Cirrhosis - enzymology | Liver Cirrhosis - chemically induced | Liver - drug effects | Cell Transdifferentiation - drug effects | Hepatitis C, Chronic - enzymology | STAT3 Transcription Factor - deficiency | NADPH Oxidases - genetics | Hepacivirus - physiology | Hepatic Stellate Cells - virology | Myofibroblasts - virology | Hepatocytes - drug effects | STAT3 Transcription Factor - genetics | Hepatic Stellate Cells - drug effects | Cyclin-Dependent Kinase Inhibitor p16 - deficiency | Hepatic Stellate Cells - enzymology | Cyclin-Dependent Kinase Inhibitor p16 - genetics | NADPH Oxidase 4 | Myofibroblasts - drug effects | Mice, Knockout | Transforming Growth Factor beta - pharmacology | Animals | Liver Cirrhosis - virology | Signal Transduction - drug effects | Biopsy | Hepatocytes - virology | Liver Cirrhosis - pathology | Mice | ATP Binding Cassette Transporter, Sub-Family B - genetics | Hepatocytes - enzymology | Oxidases | Care and treatment | Liver diseases | Research | Gene expression | Liver cells | Animal models | Biomedical research | Mesenchyme | Liver | Carbon tetrachloride | Viruses | Metastasis | Experiments | NAD(P)H oxidase | Hepatitis | Genotype & phenotype | Cell activation | NOX4 protein | Rodents | Hepatology | Gastroenterology | CYBB protein | Fibroblasts | Growth factors | Medical research | Stellate cells | Patients | Pulmonary fibrosis | Hepatocytes | Cell death | Fibrosis | Hepatitis C virus | Hepatitis C | Cancer | Apoptosis | Bile | Index Medicus | Malalties del fetge | Cèl·lules hepàtiques
Journal Article
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 11/2014, Volume 147, Issue 5, pp. 1094 - 1105.e25
Background & Aims Direct-acting antivirals that target nonstructural protein 5A (NS5A), such as daclatasvir, have high potency against the hepatitis C virus... 
Gastroenterology and Hepatology | Viral Replication | Viral Replication Factory | Drug Mechanism | Chronic Hepatitis C | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Minor Histocompatibility Antigens | Humans | Protein Multimerization | Drug Resistance, Viral | Imidazoles - chemistry | Hepacivirus - genetics | Structure-Activity Relationship | Protease Inhibitors - pharmacology | Viral Nonstructural Proteins - chemistry | Transfection | Time Factors | Antiviral Agents - chemistry | Drug Design | Molecular Structure | Binding Sites | Cell Membrane - drug effects | Hepatocytes - drug effects | Hepacivirus - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Protease Inhibitors - chemistry | Viral Nonstructural Proteins - genetics | Cell Membrane - ultrastructure | Imidazoles - pharmacology | Phosphotransferases (Alcohol Group Acceptor) - metabolism | Host-Pathogen Interactions | Cell Membrane - enzymology | Hepacivirus - enzymology | Cell Line, Tumor | Hepatocytes - ultrastructure | Hepatocytes - virology | Cell Membrane - virology | Protein Conformation | Viral Nonstructural Proteins - metabolism | Molecular Docking Simulation | Mutation | Viral Nonstructural Proteins - antagonists & inhibitors | Hepatocytes - enzymology | Virus diseases | RNA | Hepatitis C virus | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 05/2014, Volume 146, Issue 5, pp. 1373 - 1385.e11
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 10/2008, Volume 181, Issue 7, pp. 4926 - 4935
Journal Article
Journal of Virology, ISSN 0022-538X, 12/2002, Volume 76, Issue 24, pp. 12526 - 12536
Journal Article
Journal Article